AU783463B2 - Hypodermic needle with weeping tip and method of use - Google Patents
Hypodermic needle with weeping tip and method of use Download PDFInfo
- Publication number
- AU783463B2 AU783463B2 AU22757/01A AU2275701A AU783463B2 AU 783463 B2 AU783463 B2 AU 783463B2 AU 22757/01 A AU22757/01 A AU 22757/01A AU 2275701 A AU2275701 A AU 2275701A AU 783463 B2 AU783463 B2 AU 783463B2
- Authority
- AU
- Australia
- Prior art keywords
- needle
- distal portion
- medicament
- porous
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 81
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 61
- 238000002347 injection Methods 0.000 claims abstract description 60
- 239000007924 injection Substances 0.000 claims abstract description 60
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 49
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 49
- 239000012530 fluid Substances 0.000 claims abstract description 27
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 229910052751 metal Inorganic materials 0.000 claims abstract description 16
- 239000002184 metal Substances 0.000 claims abstract description 16
- 210000002216 heart Anatomy 0.000 claims abstract description 9
- 238000010009 beating Methods 0.000 claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims abstract description 8
- 230000006378 damage Effects 0.000 claims abstract description 6
- 230000003247 decreasing effect Effects 0.000 claims abstract description 6
- 239000000919 ceramic Substances 0.000 claims abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 97
- 108090000623 proteins and genes Proteins 0.000 claims description 63
- 230000001225 therapeutic effect Effects 0.000 claims description 39
- 239000011148 porous material Substances 0.000 claims description 35
- 239000013598 vector Substances 0.000 claims description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 13
- -1 ecchystatin Proteins 0.000 claims description 9
- 239000013603 viral vector Substances 0.000 claims description 9
- 239000002502 liposome Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 230000000451 tissue damage Effects 0.000 claims description 4
- 231100000827 tissue damage Toxicity 0.000 claims description 4
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 3
- 210000001367 artery Anatomy 0.000 claims description 3
- 230000035515 penetration Effects 0.000 claims description 3
- 108010079709 Angiostatins Proteins 0.000 claims description 2
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims description 2
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000012212 insulator Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 102000012936 Angiostatins Human genes 0.000 claims 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims 1
- 241001325282 Tricardia Species 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 abstract description 6
- 210000001519 tissue Anatomy 0.000 description 53
- 210000004027 cell Anatomy 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 13
- 230000001177 retroviral effect Effects 0.000 description 13
- 238000012546 transfer Methods 0.000 description 12
- 239000013604 expression vector Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 238000000520 microinjection Methods 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000713869 Moloney murine leukemia virus Species 0.000 description 4
- 102000006601 Thymidine Kinase Human genes 0.000 description 4
- 108020004440 Thymidine kinase Proteins 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000000250 revascularization Effects 0.000 description 4
- 241001430294 unidentified retrovirus Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 3
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 241000555745 Sciuridae Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108010058699 Choline O-acetyltransferase Proteins 0.000 description 2
- 102100023460 Choline O-acetyltransferase Human genes 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 2
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 108020001096 dihydrofolate reductase Proteins 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 2
- 230000008472 epithelial growth Effects 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
- 102100028652 Gamma-enolase Human genes 0.000 description 1
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
- 101150033506 HOX gene Proteins 0.000 description 1
- 101001023043 Homo sapiens Myoblast determination protein 1 Proteins 0.000 description 1
- 101000958865 Homo sapiens Myogenic factor 5 Proteins 0.000 description 1
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000002746 Inhibins Human genes 0.000 description 1
- 108010004250 Inhibins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102100035077 Myoblast determination protein 1 Human genes 0.000 description 1
- 102100038380 Myogenic factor 5 Human genes 0.000 description 1
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 1
- 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 102000004419 dihydrofolate reductase Human genes 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 108700004025 env Genes Proteins 0.000 description 1
- 101150030339 env gene Proteins 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001400 expression cloning Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108700004026 gag Genes Proteins 0.000 description 1
- 101150098622 gag gene Proteins 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 238000010329 laser etching Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005088 multinucleated cell Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000003076 neurotropic agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 108010030416 proteoliposomes Proteins 0.000 description 1
- 229950010131 puromycin Drugs 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3286—Needle tip design, e.g. for improved penetration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M2025/0073—Tip designed for influencing the flow or the flow velocity of the fluid, e.g. inserts for twisted or vortex flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
- A61M5/3291—Shafts with additional lateral openings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Surgical Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/468688 | 1999-12-20 | ||
| US09/468,688 US6241710B1 (en) | 1999-12-20 | 1999-12-20 | Hypodermic needle with weeping tip and method of use |
| PCT/US2000/034365 WO2001045548A2 (en) | 1999-12-20 | 2000-12-18 | Surgical needle with weeping tip and method of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2275701A AU2275701A (en) | 2001-07-03 |
| AU783463B2 true AU783463B2 (en) | 2005-10-27 |
Family
ID=23860824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22757/01A Ceased AU783463B2 (en) | 1999-12-20 | 2000-12-18 | Hypodermic needle with weeping tip and method of use |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US6241710B1 (enExample) |
| EP (1) | EP1239776B1 (enExample) |
| JP (1) | JP2003517863A (enExample) |
| AT (1) | ATE355018T1 (enExample) |
| AU (1) | AU783463B2 (enExample) |
| CA (1) | CA2394860A1 (enExample) |
| DE (1) | DE60033688T2 (enExample) |
| WO (1) | WO2001045548A2 (enExample) |
Families Citing this family (229)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8079982B1 (en) | 1998-06-04 | 2011-12-20 | Biosense Webster, Inc. | Injection catheter with needle electrode |
| US6623473B1 (en) * | 1998-06-04 | 2003-09-23 | Biosense Webster, Inc. | Injection catheter with multi-directional delivery injection needle |
| US7416547B2 (en) * | 1999-03-29 | 2008-08-26 | Biosense Webster Inc. | Injection catheter |
| US6905476B2 (en) * | 1998-06-04 | 2005-06-14 | Biosense Webster, Inc. | Catheter with injection needle |
| US6623474B1 (en) * | 1998-06-04 | 2003-09-23 | Biosense Webster, Inc. | Injection catheter with needle stop |
| US6440118B2 (en) * | 1999-05-11 | 2002-08-27 | Lawrence S. Burr | Device and method to sense body substance transition |
| US6575745B2 (en) * | 2000-12-05 | 2003-06-10 | Tulsa Dental Products Inc. | Titanium alloy intraosseous anesthesia delivery device |
| US6547561B2 (en) * | 1999-06-09 | 2003-04-15 | Tulsa Dental Products Inc. | Disposable anesthesia delivery system with shortened outer sleeve and inner hollow drill |
| US6241710B1 (en) * | 1999-12-20 | 2001-06-05 | Tricardia Llc | Hypodermic needle with weeping tip and method of use |
| US6945969B1 (en) | 2000-03-31 | 2005-09-20 | Medtronic, Inc. | Catheter for target specific drug delivery |
| US6833153B1 (en) * | 2000-10-31 | 2004-12-21 | Advanced Cardiovascular Systems, Inc. | Hemocompatible coatings on hydrophobic porous polymers |
| US7807210B1 (en) * | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US8979801B2 (en) * | 2001-01-17 | 2015-03-17 | Medtronic Vascular, Inc. | Microcatheter devices and methods for targeted substance delivery |
| US6969373B2 (en) * | 2001-04-13 | 2005-11-29 | Tricardia, Llc | Syringe system |
| US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
| US7344507B2 (en) * | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| CA2448790C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Electric lancet actuator |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US6702744B2 (en) * | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
| US6749580B2 (en) | 2001-10-05 | 2004-06-15 | Medical Components, Inc. | Catheter |
| US6911014B2 (en) * | 2001-10-05 | 2005-06-28 | Medical Components, Inc. | Continuous flow peritoneal dialysis catheter |
| US8002775B2 (en) * | 2001-10-24 | 2011-08-23 | Warsaw Orthopedic, Inc. | Methods and instruments for treating pseudoarthrosis |
| US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
| US20030125677A1 (en) * | 2001-12-28 | 2003-07-03 | Becton, Dickinson And Company | Medical needle assemblies |
| US20040039340A1 (en) * | 2001-12-28 | 2004-02-26 | Becton, Dickinson And Company | Shieldable unit dose medical needle assemblies |
| US20040054334A1 (en) * | 2001-12-28 | 2004-03-18 | Prais Alfred W. | Medical needle assemblies |
| US6730059B2 (en) | 2001-12-28 | 2004-05-04 | Becton, Dickinson And Company | Medical needle assemblies |
| US20030121812A1 (en) * | 2001-12-28 | 2003-07-03 | Sprieck Terry L. | Medical needle assemblies |
| US6726649B2 (en) | 2001-12-28 | 2004-04-27 | Becton, Dickinson And Company | Medical needle assemblies |
| US20040082922A1 (en) * | 2002-02-28 | 2004-04-29 | Fleury Michael T. | Huber needle with anti-rebound safety mechanism |
| US20050027264A1 (en) * | 2002-02-28 | 2005-02-03 | Fleury Michael T. | Huber needle with anti-rebound safety mechanism |
| US6878136B2 (en) | 2002-02-28 | 2005-04-12 | Medical Product Specialists | Huber needle with anti-rebound safety mechanism |
| US6918894B2 (en) | 2002-02-28 | 2005-07-19 | Medical Product Specialists | Huber needle with anti-rebound safety mechanism |
| GB0208627D0 (en) * | 2002-04-16 | 2002-05-22 | Imprint Pharm Ltd | Needle |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7226461B2 (en) * | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| USD476419S1 (en) | 2002-05-09 | 2003-06-24 | Becton, Dickinson And Company | Medical needle assembly |
| USD471980S1 (en) | 2002-05-09 | 2003-03-18 | Becton, Dickinson And Company | Medical needle assembly |
| USD476733S1 (en) | 2002-05-09 | 2003-07-01 | Becton, Dickinson And Company | Medical needle assembly |
| USD476418S1 (en) | 2002-05-09 | 2003-06-24 | Becton, Dickinson And Company | Medical needle assembly |
| USD476417S1 (en) | 2002-05-09 | 2003-06-24 | Becton, Dickinson And Company | Medical needle assembly |
| US7033345B2 (en) * | 2002-05-21 | 2006-04-25 | Advanced Cardiovascular Systems, Inc. | Deflectable microimplant delivery system |
| US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
| AU2003257203A1 (en) * | 2002-08-06 | 2004-02-23 | Genvec, Inc. | Improved injection system |
| AU2003273306B2 (en) * | 2002-09-10 | 2009-04-30 | Becton, Dickinson And Company | Method and apparatus for epidermal delivery of a substance |
| US7400931B2 (en) * | 2002-09-18 | 2008-07-15 | Cardiac Pacemakers, Inc. | Devices and methods to stimulate therapeutic angiogenesis for ischemia and heart failure |
| US6855124B1 (en) * | 2002-10-02 | 2005-02-15 | Advanced Cardiovascular Systems, Inc. | Flexible polymer needle catheter |
| US7294132B2 (en) * | 2002-10-03 | 2007-11-13 | Wright Medical Technology, Inc. | Radially ported needle for delivering bone graft material and method of use |
| US7326196B2 (en) * | 2002-10-14 | 2008-02-05 | Breg, Inc. | Catheter assemblies for controlled movement of fluid |
| US7137182B2 (en) | 2002-11-22 | 2006-11-21 | The Boeing Company | Parallel configuration composite material fabricator |
| US8336596B2 (en) | 2002-11-22 | 2012-12-25 | The Boeing Company | Composite lamination using array of parallel material dispensing heads |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US20040147881A1 (en) * | 2003-01-24 | 2004-07-29 | Hyun Dongchul D. | Huber needle with a manually movable sleeve member for containing its injection point |
| US20060200128A1 (en) * | 2003-04-04 | 2006-09-07 | Richard Mueller | Bone anchor |
| US8383158B2 (en) | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
| US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| WO2004098683A1 (en) | 2003-05-08 | 2004-11-18 | Novo Nordisk A/S | Internal needle inserter |
| EP1475113A1 (en) * | 2003-05-08 | 2004-11-10 | Novo Nordisk A/S | External needle inserter |
| JP4509100B2 (ja) | 2003-05-08 | 2010-07-21 | ノボ・ノルデイスク・エー／エス | 取り外し可能な針挿入作動部を有する皮膚に取り付け可能な注入装置 |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US7236625B2 (en) | 2003-07-28 | 2007-06-26 | The Boeing Company | Systems and method for identifying foreign objects and debris (FOD) and defects during fabrication of a composite structure |
| EP1502613A1 (en) | 2003-08-01 | 2005-02-02 | Novo Nordisk A/S | Needle device with retraction means |
| US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| US7481826B2 (en) * | 2003-09-30 | 2009-01-27 | Ethicon, Inc. | Fluid emitting suture needle |
| US20050080410A1 (en) * | 2003-10-14 | 2005-04-14 | Scimed Life Systems, Inc. | Liquid infusion apparatus for radiofrequency tissue ablation |
| WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
| US20070073271A1 (en) * | 2003-11-15 | 2007-03-29 | Brucker Gregory G | Catheter for diagnostic imaging and therapeutic procedures |
| US7289656B2 (en) * | 2003-12-02 | 2007-10-30 | The Boeing Company | Systems and methods for determining inconsistency characteristics of a composite structure |
| US8934702B2 (en) * | 2003-12-02 | 2015-01-13 | The Boeing Company | System and method for determining cumulative tow gap width |
| WO2005065414A2 (en) | 2003-12-31 | 2005-07-21 | Pelikan Technologies, Inc. | Method and apparatus for improving fluidic flow and sample capture |
| US7282051B2 (en) * | 2004-02-04 | 2007-10-16 | Boston Scientific Scimed, Inc. | Ablation probe for delivering fluid through porous structure |
| US20050187525A1 (en) * | 2004-02-19 | 2005-08-25 | Hilgers Michael E. | Devices and methods for extracting bodily fluid |
| US7039485B2 (en) | 2004-03-12 | 2006-05-02 | The Boeing Company | Systems and methods enabling automated return to and/or repair of defects with a material placement machine |
| EP1732626A1 (en) | 2004-03-30 | 2006-12-20 | Novo Nordisk A/S | Actuator system comprising lever mechanism |
| US7193696B2 (en) * | 2004-04-12 | 2007-03-20 | United Technologies Corporation | Systems and methods for using light to indicate defect locations on a composite structure |
| WO2006011062A2 (en) | 2004-05-20 | 2006-02-02 | Albatros Technologies Gmbh & Co. Kg | Printable hydrogel for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
| WO2006032692A1 (en) | 2004-09-22 | 2006-03-30 | Novo Nordisk A/S | Medical device with cannula inserter |
| US7325771B2 (en) * | 2004-09-23 | 2008-02-05 | The Boeing Company | Splice joints for composite aircraft fuselages and other structures |
| US20060108048A1 (en) | 2004-11-24 | 2006-05-25 | The Boeing Company | In-process vision detection of flaws and fod by back field illumination |
| US7424902B2 (en) * | 2004-11-24 | 2008-09-16 | The Boeing Company | In-process vision detection of flaw and FOD characteristics |
| JP2008522754A (ja) * | 2004-12-09 | 2008-07-03 | ウェスト ファーマシューティカル サービシズ インコーポレイテッド | 後装式固定針シリンジ及びそれを有する自動注入装置 |
| US8123724B2 (en) | 2004-12-09 | 2012-02-28 | West Pharmaceutical Services Of Delaware, Inc. | Auto-injection syringe having vent device |
| JP4576222B2 (ja) * | 2004-12-17 | 2010-11-04 | 日機装株式会社 | 体内特性センサ及び生体情報モニタリングシステム |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US7889907B2 (en) | 2005-01-12 | 2011-02-15 | The Boeing Company | Apparatus and methods for inspecting tape lamination |
| US20090076451A1 (en) * | 2005-01-24 | 2009-03-19 | Nova Nordisk A/S | Medical Device with Protected Transcutaneous Device |
| US7803142B2 (en) | 2005-02-02 | 2010-09-28 | Summit Access Llc | Microtaper needle and method of use |
| US7722558B2 (en) * | 2005-02-15 | 2010-05-25 | Ott Douglas E | Trocar sleeve for jet stream condition |
| JP2006271651A (ja) * | 2005-03-29 | 2006-10-12 | Matsumoto Shika Univ | 液体注入用針部品、及びその製造方法 |
| US20060229573A1 (en) * | 2005-04-08 | 2006-10-12 | Mckinley Medical L.L.L.P. | Adjustable infusion catheter |
| US8388345B2 (en) * | 2005-04-13 | 2013-03-05 | Clifford J. Ruddle | Method for cleaning a root canal system |
| WO2006108809A1 (en) | 2005-04-13 | 2006-10-19 | Novo Nordisk A/S | Medical skin mountable device and system |
| US8235719B2 (en) | 2005-04-13 | 2012-08-07 | Endo Inventions, Llc | Apparatus for cleaning a root canal system |
| US20060234182A1 (en) * | 2005-04-13 | 2006-10-19 | Ruddle Clifford J | Apparatus for cleaning a root canal system |
| US20080125745A1 (en) * | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
| US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
| US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
| US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
| US8303972B2 (en) * | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
| US7850656B2 (en) * | 2005-04-29 | 2010-12-14 | Warsaw Orthopedic, Inc. | Devices and methods for delivering medical agents |
| US8083722B2 (en) * | 2005-04-29 | 2011-12-27 | Warsaw Orthopedic, Inc | Instrumentation for injection of therapeutic fluid into joints |
| EP1887988B1 (en) * | 2005-06-07 | 2015-08-19 | Flex Partners, Inc. | System for restoration of nutrient flow to nucleus pulposa |
| WO2007013065A2 (en) | 2005-07-25 | 2007-02-01 | Rainbow Medical Ltd. | Electrical stimulation of blood vessels |
| US7372556B2 (en) * | 2005-10-31 | 2008-05-13 | The Boeing Company | Apparatus and methods for inspecting a composite structure for inconsistencies |
| US7435947B2 (en) * | 2005-10-31 | 2008-10-14 | The Boeing Company | Apparatus and methods for integrating encoding functions in material placement machines |
| US8182444B2 (en) * | 2005-11-04 | 2012-05-22 | Medrad, Inc. | Delivery of agents such as cells to tissue |
| US7713232B2 (en) * | 2005-11-04 | 2010-05-11 | Medrad, Inc. | System for washing and processing of cells for delivery thereof to tissue |
| US7988675B2 (en) | 2005-12-08 | 2011-08-02 | West Pharmaceutical Services Of Delaware, Inc. | Automatic injection and retraction devices for use with pre-filled syringe cartridges |
| US8251963B2 (en) * | 2005-12-08 | 2012-08-28 | Boston Scientific Scimed, Inc. | Flexible needle |
| CN101401313B (zh) | 2006-03-13 | 2014-06-11 | 诺沃—诺迪斯克有限公司 | 用于使用成双通信装置的电子设备的安全配对的系统 |
| CN101460207B (zh) | 2006-06-06 | 2012-03-21 | 诺沃-诺迪斯克有限公司 | 包括皮肤可安装设备及其包装件的组件 |
| US7935092B1 (en) | 2006-07-25 | 2011-05-03 | Twin Star Medical, Inc. | Self-introducing injection and aspiration device |
| US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
| US8430861B2 (en) | 2006-08-02 | 2013-04-30 | Osprey Medical, Inc. | Microvascular obstruction detection and therapy |
| US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
| US8876754B2 (en) * | 2006-08-31 | 2014-11-04 | Bayer Medical Care Inc. | Catheter with filtering and sensing elements |
| US9480800B2 (en) | 2006-09-11 | 2016-11-01 | Custom Medical Applications | Neural injection system and related methods |
| US9888940B2 (en) | 2006-09-11 | 2018-02-13 | Custom Medical Applications | Neural injection system and related methods |
| US8377005B2 (en) | 2006-09-11 | 2013-02-19 | Custom Medical Applications | Neural injection system and related methods |
| US8449503B2 (en) | 2010-11-30 | 2013-05-28 | Custom Medical Applications | Neural injection system and related methods |
| US20080065029A1 (en) * | 2006-09-11 | 2008-03-13 | Racz N S | Nerve block needle and related methods |
| US20080086111A1 (en) * | 2006-10-09 | 2008-04-10 | Medrad, Inc. | Fluid delivery systems and volume metering in cell delivery |
| US7931651B2 (en) * | 2006-11-17 | 2011-04-26 | Wake Lake University Health Sciences | External fixation assembly and method of use |
| US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
| US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
| WO2008067362A2 (en) * | 2006-11-28 | 2008-06-05 | Medrad, Inc. | Multiple lumen diffusion catheter |
| US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
| USD567367S1 (en) * | 2007-03-14 | 2008-04-22 | Mongeon Douglas R | Stylet |
| US8690832B2 (en) * | 2007-06-13 | 2014-04-08 | Custom Medical Applications | Retrofitted neural injection system and related methods |
| CA2690806C (en) | 2007-06-13 | 2015-06-02 | Epimed International, Inc. | Safety neural injection system and related methods |
| JP2009052016A (ja) * | 2007-07-27 | 2009-03-12 | Fujifilm Corp | 組成物、成形体とその製造方法、およびフィルムとその製造方法 |
| EP2209500B1 (en) | 2007-10-31 | 2015-07-22 | Novo Nordisk A/S | Non-porous material as sterilization barrier |
| US20090131886A1 (en) | 2007-11-16 | 2009-05-21 | Liu Y King | Steerable vertebroplasty system |
| US20090131867A1 (en) | 2007-11-16 | 2009-05-21 | Liu Y King | Steerable vertebroplasty system with cavity creation element |
| US9510885B2 (en) | 2007-11-16 | 2016-12-06 | Osseon Llc | Steerable and curvable cavity creation system |
| US8538535B2 (en) | 2010-08-05 | 2013-09-17 | Rainbow Medical Ltd. | Enhancing perfusion by contraction |
| US9005106B2 (en) | 2008-01-31 | 2015-04-14 | Enopace Biomedical Ltd | Intra-aortic electrical counterpulsation |
| US20100305392A1 (en) * | 2008-01-31 | 2010-12-02 | Enopace Biomedical Ltd. | Thoracic aorta and vagus nerve stimulation |
| DE102008013854A1 (de) * | 2008-03-12 | 2009-09-24 | Siemens Aktiengesellschaft | Katheter und zugehörige medizinische Untersuchungs- und Behandlungseinrichtung |
| JP5512653B2 (ja) * | 2008-04-08 | 2014-06-04 | カロリンスカ インスティテュテット イノベーションズ エービー | 医療用腔内接続装置 |
| US8496629B2 (en) * | 2008-04-22 | 2013-07-30 | Becton, Dickinson And Company | Catheter hole having a flow breaking feature |
| US9364634B2 (en) | 2008-04-22 | 2016-06-14 | Becton, Dickinson And Company | Systems and methods for improving catheter hole array efficiency |
| US8403911B2 (en) * | 2008-04-22 | 2013-03-26 | Becton, Dickinson And Company | Systems and methods for improving catheter hole array efficiency |
| US9399112B2 (en) | 2008-04-22 | 2016-07-26 | Becton, Dickinson And Company | Catheter hole having an inclined trailing edge |
| US8974411B2 (en) * | 2008-05-21 | 2015-03-10 | Becton, Dickinson And Company | Conical diffuser tip |
| US20100010413A1 (en) * | 2008-07-09 | 2010-01-14 | Loiterman David A | Needle for Subcutaneous Port |
| US9289193B2 (en) | 2008-07-18 | 2016-03-22 | Wake Forest University Health Sciences | Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage |
| US20100130958A1 (en) * | 2008-11-26 | 2010-05-27 | David Kang | Device and Methods for Subcutaneous Delivery of High Viscosity Fluids |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US9072296B2 (en) | 2009-03-26 | 2015-07-07 | Organic Medical Ventures, L.L.C. | Transdermal venous access locking solutions |
| US9433209B2 (en) | 2009-03-26 | 2016-09-06 | Organic Medical Ventures, L.L.C. | Transdermal venous access locking solutions |
| US9427498B2 (en) | 2009-03-26 | 2016-08-30 | Organic Medical Ventures, L.L.C. | Syringe treated with transdermal venous access locking solutions and method of treating the syringe |
| US20100249747A1 (en) * | 2009-03-26 | 2010-09-30 | Organic Medical Ventures, L.L.C. | Transdermal venous access locking solution |
| BE1018521A5 (fr) | 2009-04-29 | 2011-02-01 | Cardio3 Biosciences Sa | Catheter d'injection pour la delivrance d'un agent therapeutique dans un substrat. |
| US9393382B2 (en) * | 2009-05-05 | 2016-07-19 | Robert W. Heck | High-flow tapered peripheral IV catheter with side outlets |
| US20100298832A1 (en) | 2009-05-20 | 2010-11-25 | Osseon Therapeutics, Inc. | Steerable curvable vertebroplasty drill |
| US8808246B2 (en) | 2009-07-21 | 2014-08-19 | The General Hospital Corporation | Peripheral blood sampling methods and devices |
| US20110028981A1 (en) * | 2009-07-29 | 2011-02-03 | Warsaw Orthopedic, Inc. | Bone graft measuring apparatus and method of use |
| EP2547384A4 (en) * | 2010-03-19 | 2014-07-23 | Halozyme Inc | DEVICE FOR DELIVERY OF MEDICATION WITH GAS PRESSURE |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US11419632B2 (en) * | 2010-04-23 | 2022-08-23 | Mark D. Wieczorek, P.C. | Transseptal access device and method of use |
| EP2563233B1 (en) | 2010-04-29 | 2020-04-01 | Dfine, Inc. | System for use in treatment of vertebral fractures |
| FR2964851B1 (fr) * | 2010-09-21 | 2014-05-09 | Neolix | Instrument endodontique evide au moyen d'une fente le long d'une portion de decoupe, permettant le passage d'un fluide |
| GB2486652A (en) * | 2010-12-21 | 2012-06-27 | Peak Medical Ltd | Infusion catheter with a detachable needle |
| US20120245528A1 (en) * | 2011-03-22 | 2012-09-27 | Navilyst Medical, Inc. | Catheter with porous cuff |
| US8366685B2 (en) | 2011-04-26 | 2013-02-05 | Creative Vascular, Llc | Systems and methods for phlebotomy through a peripheral IV catheter |
| US10076272B2 (en) | 2011-04-26 | 2018-09-18 | Velano Vascular, Inc. | Systems and methods for phlebotomy through a peripheral IV catheter |
| US9186100B2 (en) | 2011-04-26 | 2015-11-17 | Velano Vascular, Inc. | Systems and methods for phlebotomy through a peripheral IV catheter |
| US9089438B2 (en) | 2011-06-28 | 2015-07-28 | Spinal Elements, Inc. | Apparatus for promoting movement of nutrients to intervertebral space and method of use |
| US9056182B2 (en) | 2011-08-23 | 2015-06-16 | Becton, Dickinson And Company | Catheter having a pressure activated splittable feature |
| US9402975B2 (en) | 2011-08-31 | 2016-08-02 | Becton, Dickinson And Company | Systems and methods to increase rigidity and snag-resistance of catheter tip |
| PL2750501T3 (pl) | 2011-08-31 | 2018-12-31 | Organic Medical Ventures, L.L.C. | Roztwory zabezpieczające z przezskórnym dostępem dożylnym |
| US9526637B2 (en) | 2011-09-09 | 2016-12-27 | Enopace Biomedical Ltd. | Wireless endovascular stent-based electrodes |
| US8855783B2 (en) | 2011-09-09 | 2014-10-07 | Enopace Biomedical Ltd. | Detector-based arterial stimulation |
| US20130345665A1 (en) * | 2012-06-26 | 2013-12-26 | Gary Swaddle | Catheter system |
| CN104902836B (zh) | 2012-11-05 | 2017-08-08 | 毕达哥拉斯医疗有限公司 | 受控组织消融 |
| US9770593B2 (en) | 2012-11-05 | 2017-09-26 | Pythagoras Medical Ltd. | Patient selection using a transluminally-applied electric current |
| EP2740422A1 (en) | 2012-12-05 | 2014-06-11 | Custom Medical Applications | Safety neural injection system and related methods |
| JP2014180571A (ja) | 2013-03-15 | 2014-09-29 | Custom Medical Applications | 安全な神経注射システム及び関連する方法 |
| US9295512B2 (en) | 2013-03-15 | 2016-03-29 | Myoscience, Inc. | Methods and devices for pain management |
| US9610112B2 (en) * | 2013-03-15 | 2017-04-04 | Myoscience, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
| WO2015068167A2 (en) | 2013-11-06 | 2015-05-14 | Enopace Biomedical Ltd. | Wireless endovascular stent-based electrodes |
| WO2015117620A1 (en) * | 2014-02-05 | 2015-08-13 | Biontech Ag | A cannula, an injection or infusion device and methods of using the cannula or the injection or infusion device |
| WO2015168391A1 (en) * | 2014-05-02 | 2015-11-05 | Cedars-Sinai Medical Center | Injection catheter and catheter console platform |
| EP3139853B1 (en) | 2014-05-07 | 2018-12-19 | Pythagoras Medical Ltd. | Controlled tissue ablation apparatus |
| WO2015171754A1 (en) * | 2014-05-07 | 2015-11-12 | Massachusetts Institute Of Technology | Debridement apparatus using linear lorentz-force motors |
| US10383685B2 (en) | 2015-05-07 | 2019-08-20 | Pythagoras Medical Ltd. | Techniques for use with nerve tissue |
| US20160346513A1 (en) * | 2015-05-26 | 2016-12-01 | Vanderbilt University | Surgical device tip with arc length varying curvature |
| US10912922B2 (en) | 2015-07-02 | 2021-02-09 | Covellus Llc | Modular medical device catheter system |
| US10814120B2 (en) | 2015-07-02 | 2020-10-27 | Covellus Llc | Modular medical device catheter system |
| US10265482B2 (en) * | 2015-10-01 | 2019-04-23 | Soul Skins Llc | Needle-point pen apparatus, methods, and systems for administering medication |
| US10300247B2 (en) | 2016-02-03 | 2019-05-28 | Velano Vascular, Inc. | Devices and methods for fluid transfer through a placed peripheral intravenous catheter |
| US11045601B2 (en) | 2016-04-22 | 2021-06-29 | Eli Lilly And Company | Infusion set with components comprising a polymeric sorbent to reduce the concentration of m-cresol in insulin |
| WO2017199240A2 (en) | 2016-05-18 | 2017-11-23 | Pythagoras Medical Ltd. | Helical catheter |
| US9744344B1 (en) | 2016-06-30 | 2017-08-29 | Velano Vascular, Inc. | Devices and methods for catheter placement within a vein |
| US10610668B2 (en) | 2016-10-05 | 2020-04-07 | Becton, Dickinson And Company | Catheter with an asymmetric tip |
| CN109862834B (zh) | 2016-10-27 | 2022-05-24 | Dfine有限公司 | 具有接合剂递送通道的可弯曲的骨凿 |
| JP7256119B2 (ja) | 2016-11-28 | 2023-04-11 | ディファイン インコーポレイテッド | 腫瘍切除装置及び関連する方法 |
| US10463380B2 (en) | 2016-12-09 | 2019-11-05 | Dfine, Inc. | Medical devices for treating hard tissues and related methods |
| WO2018129180A1 (en) | 2017-01-06 | 2018-07-12 | Dfine, Inc. | Osteotome with a distal portion for simultaneous advancement and articulation |
| US20220401261A1 (en) * | 2017-12-07 | 2022-12-22 | Harry Michael Lambert | Ophthalmological surgery microsurgery instruments and methods of use in pars plana vitrectomy for increasing surgical precision and reducing vitreoretinal instrument insertions and removals and related trauma |
| EP4385409A3 (en) | 2017-03-21 | 2024-09-25 | Velano Vascular, Inc. | Devices for fluid transfer through a placed peripheral intravenous catheter |
| EP3600514B1 (en) | 2017-03-21 | 2022-06-08 | Velano Vascular, Inc. | Systems and methods for controlling catheter device size |
| CN107821996B (zh) * | 2017-12-05 | 2023-06-09 | 安徽至诚和信食品科技有限公司 | 盐水注射机用自清洁双头注射针 |
| WO2020097339A1 (en) | 2018-11-08 | 2020-05-14 | Dfine, Inc. | Tumor ablation device and related systems and methods |
| US11554197B2 (en) * | 2018-11-20 | 2023-01-17 | BioMark, LLC | Device with an open cell element |
| CN119033431A (zh) | 2019-04-30 | 2024-11-29 | 波士顿科学国际有限公司 | 内窥镜贴片施用器 |
| CN114599419B (zh) | 2019-08-20 | 2024-10-18 | 威蓝诺血管股份有限公司 | 具有延长导管的流体输送装置及其使用方法 |
| WO2021055617A1 (en) | 2019-09-18 | 2021-03-25 | Merit Medical Systems, Inc. | Osteotome with inflatable portion and multiwire articulation |
| DE112020006978T5 (de) * | 2020-03-27 | 2023-01-05 | Japan Lifeline Co., Ltd. | Medikamentenlösungsinjektionsnadel und Medikamentenlösungsinjektionsnadelsystem |
| JP7373056B2 (ja) * | 2020-03-27 | 2023-11-01 | 日本ライフライン株式会社 | 薬液注入針および薬液注入針システム |
| CN111420169A (zh) * | 2020-04-09 | 2020-07-17 | 广州医科大学附属肿瘤医院 | 一种侧孔针针头 |
| CN111420176B (zh) * | 2020-05-15 | 2022-07-05 | 梁徐涛 | 一种医疗输液防脱插头 |
| CN111420175B (zh) * | 2020-05-15 | 2021-11-02 | 咸宁市中心医院 | 一种医用输液瓶插头 |
| MX2023006170A (es) | 2020-11-26 | 2023-06-08 | Avia Vascular Llc | Dispositivos, sistemas y metodos de recoleccion de sangre. |
| US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
| WO2023137079A1 (en) * | 2022-01-11 | 2023-07-20 | Covellus Llc | Adapter for an electrical modular catheter system |
| EP4580721A1 (en) | 2022-09-02 | 2025-07-09 | Universiteit Gent | Catheter for delivery of therapeutic liquid formulation |
| CN117797361A (zh) * | 2024-01-10 | 2024-04-02 | 北京大学口腔医学院 | 一种利于局部均匀注射针头 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4512768A (en) * | 1982-09-10 | 1985-04-23 | Avvari Rangaswamy | Analgesic syringe |
| WO1999004851A1 (en) * | 1997-07-22 | 1999-02-04 | Emed Corporation | Iontophoretic delivery of an agent into cardiac tissue |
| WO1999049926A2 (en) * | 1998-03-31 | 1999-10-07 | Cardiogenesis Corporation | Delivery of an angiogenic substance |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE374641C (de) | 1923-04-27 | Ernst Kallmeyer | Katheter | |
| US1124851A (en) | 1913-03-26 | 1915-01-12 | Edward E Burkle | Process for curing meats. |
| US1192596A (en) | 1915-09-16 | 1916-07-25 | Benjamin K Albrecht | Apparatus for injecting brine into meat. |
| US1370788A (en) | 1919-07-21 | 1921-03-08 | Good Frank Hoyze | Meat-curing injector |
| US2112629A (en) | 1936-09-29 | 1938-03-29 | Lloyd Russel | Trocar |
| US3076457A (en) | 1961-02-14 | 1963-02-05 | Copen Simon Irving | Hypodermic needle |
| US4186745A (en) | 1976-07-30 | 1980-02-05 | Kauzlarich James J | Porous catheters |
| US4173981A (en) * | 1977-05-23 | 1979-11-13 | University Of Utah | Cannula for arterial and venous bypass cannulation |
| US4256102A (en) * | 1979-05-14 | 1981-03-17 | Monaco Anthony P | Subcutaneous dialysis system |
| US4411657A (en) | 1980-05-19 | 1983-10-25 | Anibal Galindo | Hypodermic needle |
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| US4952496A (en) | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| SE442377B (sv) * | 1984-06-29 | 1985-12-23 | Mediplast Ab | Kateter, sond eller liknande anordning |
| US4838877A (en) | 1985-08-06 | 1989-06-13 | Massau Bruce A | Polymeric hypodermic device |
| JPH02142576A (ja) * | 1988-11-25 | 1990-05-31 | Japan Gore Tex Inc | カテーテル |
| US5021044A (en) * | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
| DE69034168T3 (de) | 1989-03-21 | 2013-04-11 | Vical, Inc. | Expression von exogenen Polynukleotidsequenzen in Wirbeltieren |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US4968306A (en) * | 1989-07-07 | 1990-11-06 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter having an adjustable length infusion section to delivery therapeutic fluid |
| DE3943412A1 (de) * | 1989-12-30 | 1991-07-11 | Braun Melsungen Ag | Transcutaner implantatkatheter |
| US5069673A (en) * | 1990-02-07 | 1991-12-03 | Cordis Corporation | Catheter with double step-down bore |
| US5085635A (en) | 1990-05-18 | 1992-02-04 | Cragg Andrew H | Valved-tip angiographic catheter |
| JPH06503972A (ja) * | 1990-06-26 | 1994-05-12 | アドヴァンスド カーディオヴァスキュラーシステムズ インコーポレイテッド | 薬剤の血管内供給方法およびそのためのカテーテル |
| US6224608B1 (en) | 1990-08-10 | 2001-05-01 | United States Surgical Corporation | Tissue holding device and method |
| US5147334A (en) | 1991-01-02 | 1992-09-15 | Moss James P | Catheter for cholangiography |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5254106A (en) | 1992-04-17 | 1993-10-19 | Feaster Fred T | Hydrodissection needle |
| US5380307A (en) | 1992-09-30 | 1995-01-10 | Target Therapeutics, Inc. | Catheter with atraumatic drug delivery tip |
| WO1994011042A1 (fr) | 1992-11-10 | 1994-05-26 | Seikagaku Kogyo Kabushiki Kaisha | Injecteur et son utilisation |
| US5389074A (en) * | 1993-10-27 | 1995-02-14 | The Regents Of The University Of California | Body insertion tube with anesthetic jacket |
| US5425723A (en) * | 1993-12-30 | 1995-06-20 | Boston Scientific Corporation | Infusion catheter with uniform distribution of fluids |
| ATE245013T1 (de) | 1994-09-02 | 2003-08-15 | Oversby Pty Ltd | Phaco-emulsifikationsnadel mit kerben |
| US5713861A (en) * | 1994-10-17 | 1998-02-03 | Vanarthos; William | Trauma urethral catheter and method of using same |
| US5569197A (en) * | 1994-12-21 | 1996-10-29 | Schneider (Usa) Inc | Drug delivery guidewire |
| EP0727187B1 (en) | 1995-02-15 | 2003-08-06 | Joseph Eldor | Multiple hole spinal needle |
| US6010495A (en) | 1995-03-17 | 2000-01-04 | Tilton, Jr.; Eugene B. | Instrumentation for endoscopic surgical insertion and application of liquid, gel and like material |
| DE19512607A1 (de) | 1995-04-04 | 1996-10-10 | Johann Dr Med Rull | Völlig tragmentationsfreie Kanülen |
| US5603703A (en) | 1995-04-28 | 1997-02-18 | Medtronic, Inc. | Selectively aspirating stylet |
| US6007479A (en) | 1996-07-08 | 1999-12-28 | H.D.S. Systems Ltd. | Heart assist system and method |
| US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
| WO1997015341A1 (en) | 1995-10-23 | 1997-05-01 | Racz Gabor J Jr | Stellate block needle |
| US5643228A (en) | 1995-11-13 | 1997-07-01 | Uresil Corporation | Catheter |
| US5662619A (en) | 1995-11-27 | 1997-09-02 | Zarate; Alfredo R. | Venous dialysis needle |
| US5800407A (en) | 1995-12-21 | 1998-09-01 | Eldor; Joseph | Multiple hole epidural catheter |
| US5738649A (en) * | 1996-04-16 | 1998-04-14 | Cardeon Corporation | Peripheral entry biventricular catheter system for providing access to the heart for cardiopulmonary surgery or for prolonged circulatory support of the heart |
| FR2747908B1 (fr) * | 1996-04-25 | 1998-12-04 | Chout Philippe | Suture irrigatrice |
| US6117125A (en) * | 1996-05-02 | 2000-09-12 | Cook Incorporated | Method for predetermining uniform flow rate of a fluid from a tubular body and device therefrom |
| HUP0002102A3 (en) | 1996-06-10 | 2001-02-28 | Elan Corp Plc | Needle for subcutaneous delivery of fluids |
| IE80772B1 (en) * | 1996-06-10 | 1999-02-10 | Elan Corp Plc | Delivery needle |
| US5735831A (en) | 1996-07-10 | 1998-04-07 | Cordis Corporation | Expandable flowrate catheter assembly and method of making same |
| US5913856A (en) | 1997-05-19 | 1999-06-22 | Irvine Biomedical, Inc. | Catheter system having a porous shaft and fluid irrigation capabilities |
| US6063069A (en) | 1997-05-19 | 2000-05-16 | Micro Therapeutics Inc. | Method and apparatus for power lysis of a thrombus |
| US5957901A (en) | 1997-10-14 | 1999-09-28 | Merit Medical Systems, Inc. | Catheter with improved spray pattern for pharmaco-mechanical thrombolysis therapy |
| US5885252A (en) | 1998-06-03 | 1999-03-23 | Liu; Wen-Neng | Automatic safety infusion catheter needle |
| US6162202A (en) | 1998-10-26 | 2000-12-19 | Sicurelli; Robert | Flexible syringe needle |
| FR2790965B3 (fr) * | 1999-03-19 | 2001-04-20 | Henri Mehier | Dispositif destine a assurer la delivrance de vapeur directement au sein de tout ou partie d'un organe cible humain ou animal, installation destinee a l'injection de vapeur dans ledit dispositif |
| WO2000029055A1 (fr) * | 1998-11-17 | 2000-05-25 | Henri Mehier | Dispositif destine a assurer la delivrance d'une substance active directement au sein d'un tissu cellulaire, moyen d'implantation du dispositif et appareils destines a l'injection de substance active dans ledit dispositif |
| US6210376B1 (en) | 1999-04-08 | 2001-04-03 | New York University | Cannulated delivery pin |
| US6497698B1 (en) | 1999-05-20 | 2002-12-24 | Cardiac Assist, Inc. | Method and apparatus for treating a patient |
| US6350253B1 (en) | 1999-07-19 | 2002-02-26 | I-Flow Corporation | Catheter for uniform delivery of medication |
| US6241710B1 (en) | 1999-12-20 | 2001-06-05 | Tricardia Llc | Hypodermic needle with weeping tip and method of use |
| US6464662B1 (en) | 2000-07-26 | 2002-10-15 | Image-Guided Neurologics, Inc. | Drug delivery and catheter systems, apparatus and processes |
| EP1397011B1 (en) | 2001-03-01 | 2008-09-17 | Mitsubishi Denki Kabushiki Kaisha | Mobile ip packet communication system |
-
1999
- 1999-12-20 US US09/468,688 patent/US6241710B1/en not_active Expired - Fee Related
-
2000
- 2000-12-18 WO PCT/US2000/034365 patent/WO2001045548A2/en not_active Ceased
- 2000-12-18 EP EP00986533A patent/EP1239776B1/en not_active Expired - Lifetime
- 2000-12-18 AT AT00986533T patent/ATE355018T1/de not_active IP Right Cessation
- 2000-12-18 CA CA002394860A patent/CA2394860A1/en not_active Abandoned
- 2000-12-18 JP JP2001546291A patent/JP2003517863A/ja active Pending
- 2000-12-18 DE DE60033688T patent/DE60033688T2/de not_active Expired - Fee Related
- 2000-12-18 AU AU22757/01A patent/AU783463B2/en not_active Ceased
-
2001
- 2001-04-09 US US09/829,022 patent/US6547769B2/en not_active Expired - Fee Related
-
2003
- 2003-01-14 US US10/342,023 patent/US6855132B2/en not_active Expired - Fee Related
-
2004
- 2004-05-26 US US10/855,026 patent/US6949087B2/en not_active Expired - Fee Related
-
2005
- 2005-09-02 US US11/218,700 patent/US7252654B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4512768A (en) * | 1982-09-10 | 1985-04-23 | Avvari Rangaswamy | Analgesic syringe |
| WO1999004851A1 (en) * | 1997-07-22 | 1999-02-04 | Emed Corporation | Iontophoretic delivery of an agent into cardiac tissue |
| WO1999049926A2 (en) * | 1998-03-31 | 1999-10-07 | Cardiogenesis Corporation | Delivery of an angiogenic substance |
Also Published As
| Publication number | Publication date |
|---|---|
| US7252654B2 (en) | 2007-08-07 |
| US6547769B2 (en) | 2003-04-15 |
| ATE355018T1 (de) | 2006-03-15 |
| CA2394860A1 (en) | 2001-06-28 |
| US6855132B2 (en) | 2005-02-15 |
| AU2275701A (en) | 2001-07-03 |
| US20030130626A1 (en) | 2003-07-10 |
| DE60033688T2 (de) | 2007-11-15 |
| DE60033688D1 (de) | 2007-04-12 |
| US6949087B2 (en) | 2005-09-27 |
| EP1239776A2 (en) | 2002-09-18 |
| US20010023349A1 (en) | 2001-09-20 |
| WO2001045548A3 (en) | 2002-01-10 |
| WO2001045548A2 (en) | 2001-06-28 |
| EP1239776B1 (en) | 2007-02-28 |
| US20040220536A1 (en) | 2004-11-04 |
| JP2003517863A (ja) | 2003-06-03 |
| US20050288651A1 (en) | 2005-12-29 |
| US6241710B1 (en) | 2001-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU783463B2 (en) | Hypodermic needle with weeping tip and method of use | |
| EP0928135B1 (en) | System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment | |
| JP5581692B2 (ja) | 目的の薬物送出のためのマイクロカテーテル器具および方法 | |
| US6796957B2 (en) | Sterile aspiration/reinjection systems | |
| AU2002318290B2 (en) | Methods for sterile aspiration/reinjection of bodily fluid | |
| US20020095124A1 (en) | Lateral needle-less injection apparatus and method | |
| AU2002318290A1 (en) | Methods for sterile aspiration/reinjection of bodily fluid | |
| AU2002320376A1 (en) | Sterile aspiration/reinjection systems | |
| US20040236377A1 (en) | System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment | |
| CA2261022C (en) | System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment | |
| CA2547967A1 (en) | System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND INVENTION TITLE TO READ: HYPODERMIC NEEDLE WITH WEEPING TIP AND METHOD OF USE |